Focus Investment Banking

AUGUST 6, 2023

ESG isn’t just a matter for large, publicly traded companies. This is particularly true if your partners are publicly traded or foreign-owned. It’s increasingly becoming a must for small and medium-sized businesses. Strength in ESG helps reduce companies’ risk of adverse government action,” adds McKinsey.

Middle Market 52

Middle Market Business Government Profitability 52

The TRADE

JULY 11, 2023

The FCA now has the task of preserving this sensitive balance in the detailed rules that come out next year,” Mike Carrodus, chief executive of Substantive Research, told The TRADE. “The call for a research platform is a clear indication that the market is struggling to match supply and demand effectively, despite overwhelming demand.

Asset Management 40

Asset Management Investment Government Capital Market 40

Cooley M&A

JANUARY 22, 2020

If, however, capital markets and the economy weaken in 2020, M&A transactions may be the only viable option for life sciences companies to access capital, in which case we would expect to see more M&A transactions by number, but they would likely be paired with lower purchase prices and/or more highly structured.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

Cooley M&A

JANUARY 25, 2023

Will 2023 see a resurgence of traditional public M&A deals or will macro factors and the looming threat of regulatory review continue to push biotechnology companies down creative paths? It’s a more challenging market environment right now than we’ve seen in many years,” said Charlie Kim , who co-chairs Cooley’s capital markets practice.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 22, 2021

A series of blockbuster deals rallied the NASDAQ 100 Technology Index to trade more than 20% higher than 2019, and Q3 2020 recorded the highest global M&A deal value in the technology sector this decade. [2] Apologies in advance to our capital markets colleagues – it looks like we’re not done with you just yet!).

M&A 40

M&A IPO Mergers and Acquisitions Business 40

Cooley M&A

OCTOBER 29, 2020

On September 24, Cooley M&A partner, Garth Osterman, moderated a webinar on the current trend in going public: SPACs! which is unsurprising considering that the vast majority of SPACs that have announced business combinations are trading above $10.00 SPAC vs. IPO. Revisiting Governance Documentation.

M&A 52

M&A IPO Valuation Mergers and Acquisitions 52

Cooley M&A

JANUARY 20, 2022

19 treatments from Pfizer, Merck and potentially others hitting the market soon , we expect Big Pharma to continue to parlay this cash flow into growth in other areas of strategic focus. The strong capital markets environment that has prevailed during the past few years has enabled a large number of development-stage and one?product,

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

In the US, the Federal Trade Commission and the Department of Justice under the Biden administration have shifted their priorities and rhetoric in favor of tougher enforcement, with consolidation in the tech sector being one of their top targets.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52